Improving bladder voiding efficiency with shockwave therapy
Can Acupoint Low Intensity Shockwave Therapy Improve Bladder Voiding Efficiency: A Pilot Study.
NA · Taichung Armed Forces General Hospital · NCT06020963
This study is testing whether combining shockwave therapy with acupuncture can help people with bladder issues empty their bladders more effectively.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 100 (estimated) |
| Ages | 20 Years and up |
| Sex | All |
| Sponsor | Taichung Armed Forces General Hospital (other gov) |
| Locations | 1 site (Taichung, Other (Non US)) |
| Trial ID | NCT06020963 on ClinicalTrials.gov |
What this trial studies
This clinical trial investigates the effectiveness of low-intensity extracorporeal shockwave therapy (LiESWT) combined with acupuncture to enhance bladder voiding efficiency in patients with detrusor underactivity. It is a randomized controlled trial involving 100 participants, aged 20 and older, who will be assigned to different treatment groups receiving LiESWT at specific acupoints or oral medication. The primary goal is to assess improvements in bladder voiding efficiency, while secondary outcomes include various urinary function metrics. This approach aims to provide a non-invasive treatment option for urinary dysfunction, particularly in the elderly population.
Who should consider this trial
Good fit: Ideal candidates are adults over 20 years old with a bladder voiding efficiency of less than 70%.
Not a fit: Patients with active pelvic malignancy, urinary tract infections, or those who are pregnant will not benefit from this study.
Why it matters
Potential benefit: If successful, this treatment could significantly improve bladder function and quality of life for patients with urinary dysfunction.
How similar studies have performed: Previous studies have shown promising results for LiESWT in treating urinary dysfunction, indicating potential for success in this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1.Bladder voiding efficiency is less than 70%. Exclusion Criteria: 1. Patient who has history active pelvic malignancy without treatment. 2. Acute urinary tract infection. 3. Pregnancy 4. Active infective lesion on treatment site. 5. Open wound on treatment site.
Where this trial is running
Taichung, Other (Non US)
- Taichung Armed Forces General Hospital — Taichung, Other (Non US), Taiwan (RECRUITING)
Study contacts
- Principal investigator: Jing-Dung Shen, MD — Taichung Armed Forces General Hospital
- Study coordinator: Jing-Dung Shen, MD
- Email: jdwhydo@gmail.com
- Phone: +886958878129
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Detrusor Underactivity, detrusor underactivity, acupoint, voiding dysfunction, bladder voiding efficiency, low-intensity extracorporeal shockwave therapy